FDA product code QVA: Fludeoxyglucose F18-Guided Radiation Therapy System
QVA is the FDA product code for fludeoxyglucose f18-guided radiation therapy system. It is a Class II device, regulated under 21 CFR 892.5060 and reviewed by the Radiology panel. FDA has cleared 1 510(k) submission under QVA, 1 in the last five years. The average 510(k) review took 170 days (median 170); 170 days on average over the last three years. 1 De Novo request was granted under it. FDA has posted 3 recalls for QVA devices, 3 initiated in the last five years.
Definition
A fludeoxyglucose F18-guided radiation therapy system is a device that combines the functionality of an emission computed tomography detection system and a linear accelerator. The device is intended for use with approved fludeoxyglucose F18. The emission computed tomography detection system acquires images of positron-emitting fludeoxyglucose F18 for the purpose of guiding the delivery of megavoltage X-rays for oncologic treatment with radiation therapy using an FDA cleared, authorized, or approved linear accelerator.
Classification
| Field | Value |
|---|---|
| Device name | Fludeoxyglucose F18-Guided Radiation Therapy System |
| Device class | Class II |
| Regulation | 21 CFR 892.5060 |
| Review panel | RA — Radiology |
| Medical specialty | Radiology |
| Premarket route | 510(k) |
510(k) clearances per year for QVA
| Year | Clearances | Avg. review days |
|---|---|---|
| 2025 | 1 | 170 |
Compare with all 510(k) review times · Search every QVA clearance
Top QVA applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Reflexion Medical, Inc. | 1 | 2025-12-18 |
Most recent QVA clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K252071 | Reflexion Medical, Inc. | RefleXion Medical Radiotherapy System, Reflexion X2 | 2025-12-18 | 170 |
Recalls for QVA devices
3 product recalls in 3 recall events; 3 initiated in the last five years and 3 still open. Most recent: 2026-02-09.
| Year | Recalls |
|---|---|
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Frequently asked questions
What is FDA product code QVA?
QVA is the FDA product code for fludeoxyglucose f18-guided radiation therapy system. It is a Class II device, regulated under 21 CFR 892.5060 and reviewed by the Radiology panel.
What device class is QVA?
Class II, regulation 21 CFR 892.5060. Typical premarket route: 510(k).
How long does a 510(k) take for product code QVA?
Across 1 cleared submissions the average was 170 days from receipt to decision (median 170).
Which companies have the most QVA clearances?
Reflexion Medical, Inc. (1).
Have QVA devices been recalled?
Yes: 3 product recalls across 3 recall events; the most recent began 2026-02-09.
Next steps
- Run an FDA pathway report with predicate devices for product code QVA
- Run a recall and safety report across every QVA manufacturer
- Watch product code QVA for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Radiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times